Tag: #Eisai

1 articles

Title	Company	Published
FDA extends review of weekly LEQEMBI IQLIK for initial Alzheimer's use to Aug. 24, 2026 #FDA #Alzheimer's disease #LEQEMBI IQLIK #Biogen #Eisai	Tervion	May 9, 2026

#Eisai News | Tervion